Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Shares Jump 12 Percent on European Patent Award

NEW YORK, March 16 (GenomeWeb News) - Shares of CombiMatrix were up 12.4 percent, or $.24, at $2.18 in afternoon trading after parent Acacia announced that the European patent office had granted CombiMatrix a patent titled "self-assembling arrays" (EP1185363B1).

 

The patent was registered in Germany, France, Spain, Great Britain, and Italy, the company said in a statement.

 

A corresponding patent is pending in the US.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.